Mylan CEO Heather Bresch pauses as she prepares to testify on Capitol Hill in Washington, Wednesday, Sept. 21, 2016, before the House Oversight Committee hearing on EpiPen price increases. Bresch defended the cost for life-saving EpiPens, signaling the company has no plans to lower prices despite a public outcry and questions from skeptical lawmakers. (AP Photo/Pablo Martinez Monsivais)
Featured Photo Galleries
